Characteristics of Different Types of Safety Lancets on Blood Volume and Perceived Pain in Male and Female Volunteers

NCT ID: NCT04001348

Last Updated: 2019-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-30

Study Completion Date

2013-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study was a randomized, single blind, uni-center pivotal study in male and female healthy volunteers, to determine capillary blood volume and pain perception obtained in a process of puncturing with different safety lancets.

A group of one hundred (100) healthy Caucasian male and female Subjects (aged \> 18 to \< 65 years old was randomized ) who were in good physical and mental condition. The Subjects had 4 (four) fingers (two fingers from each hand) lanced each with a different type of safety lancet. Overall, 4 (four) different safety lancets were investigated per each Subject.

Overall, 16 (sixteen) different safety lancets (4 different safety lancets per one Subject) were investigated, the capillary blood volume and pain were measured.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

safety lancets lancet capillary blood capillary blood sampling blood volume pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HTL-STREFA S.A.safety lancet type 610

Group Type EXPERIMENTAL

Acti-Lance Lite

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Acti-Lance Universal

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Acti-Lance Special

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

HTL-STREFA S.A.safety lancet type 553-556

Group Type EXPERIMENTAL

Medlance Plus Super Lite

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Medlance Plus Lite

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Medlance Plus Universal

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Medlance Plus Extra

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Medlance Plus Special

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

HTL-STREFA S.A.safety lancet type 430

Group Type EXPERIMENTAL

Prolance Micro Flow

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Prolance Low Flow

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Prolance Normal Flow

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Prolance High Flow

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Prolance Max Flow

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Prolance Pediatric

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

HTL-STREFA S.A.safety lancet type 520

Group Type EXPERIMENTAL

MediSafe Solo 29 Gauge

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

MediSafe Solo 23 Gauge

Intervention Type DEVICE

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Acti-Lance Lite

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Acti-Lance Universal

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Acti-Lance Special

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Medlance Plus Super Lite

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Medlance Plus Lite

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Medlance Plus Universal

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Medlance Plus Extra

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Medlance Plus Special

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Prolance Micro Flow

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Prolance Low Flow

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Prolance Normal Flow

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Prolance High Flow

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Prolance Max Flow

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Prolance Pediatric

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

MediSafe Solo 29 Gauge

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

MediSafe Solo 23 Gauge

Finger lancing was undertaken in a standardized way and was performed by medical staff trained from lancing procedure described in the Protocol.

Total blood collection time was recorded in the source documentation and then volume of the blood was measured using a calibrated ruler. Perceived pain was assessed on the visual analog scale (VAS, numeric scale). VAS scale was assessed 5 minutes after the lancing procedure.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

HTL-STREFA S.A.safety lancet type 610 HTL-STREFA S.A.safety lancet type 610 HTL-STREFA S.A.safety lancet type 610 HTL-STREFA S.A.safety lancet type 553-556 HTL-STREFA S.A.safety lancet type 553-556 HTL-STREFA S.A.safety lancet type 553-556 HTL-STREFA S.A.safety lancet type 553-556 HTL-STREFA S.A.safety lancet type 553-556 HTL-STREFA S.A.safety lancet type 430 HTL-STREFA S.A.safety lancet type 430 HTL-STREFA S.A.safety lancet type 430 HTL-STREFA S.A.safety lancet type 430 HTL-STREFA S.A.safety lancet type 430 HTL-STREFA S.A.safety lancet type 430 HTL-STREFA S.A.safety lancet type 520 HTL-STREFA S.A.safety lancet type 520

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Willing to sign the informed consent.
* Male and female volunteers.
* Age between 18 and 65 inclusive.
* Able to communicate well with the Investigator and comply with the requirements of the study.
* Volunteers who are in good physical and mental health.

Exclusion Criteria

* Pregnancy or breastfeeding (self-reported).
* Confirmed or suspected malignant cancer History of poor blood circulation.
* Any skin condition on his or her fingers that prevents blood sampling.
* Anxiety with needles or finger pricks.
* Clotting disorders (including bleeding) in medical history.
* Neuropathy or other condition affecting sensation in the hands.
* History of blood borne infection (e.g., HIV, hepatitis B or C, syphilis, malaria, babesiosis, brucellosis, leptospirosis, arboviral infections, relapsing fever, T lymphotropic virus Type 1, Creutzfeldt-Jakob disease).
* Currently participating in another study.
* History of drug or alcohol abuse within the 12 months prior to screening or evidence of such abuse.
* Intake of alcohol within 48 hours prior to the start of the study (self-reporting).
* Donation or loss of 400 mL or more of blood within 4 weeks prior to the start of the study.
* Any other condition that in the Investigator opinion may negatively influence Subject's participation in the study.
* Intake of medicines that affect blood coagulability (including anticoagulants such as vitamin K, antivirals and anticoagulants such as heparin, aspirin, thrombin inhibitors, vitamin K antagonists).
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HTL-Strefa S.A.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Monipol Clinical Pharmacology Research Centre

Krakow, Lesser Poland Voivodeship, Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

References

Explore related publications, articles, or registry entries linked to this study.

Serafin A, Malinowski M, Prazmowska-Wilanowska A. Blood volume and pain perception during finger prick capillary blood sampling: are all safety lancets equal? Postgrad Med. 2020 Apr;132(3):288-295. doi: 10.1080/00325481.2020.1717160. Epub 2020 Feb 6.

Reference Type DERIVED
PMID: 32027205 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Mp05.13

Identifier Type: -

Identifier Source: org_study_id